We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+23.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$145M
AUM Growth
+$10.7M
Cap. Flow
-$39.5M
Cap. Flow %
-27.17%
Top 10 Hldgs %
27.16%
Holding
316
New
137
Increased
28
Reduced
59
Closed
75

Top Buys

1
CNC icon
Centene
CNC
+$6.93M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$4.78M
3
UNH icon
UnitedHealth
UNH
+$3.65M
4
CVS icon
CVS Health
CVS
+$3.53M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.17M

Top Sells

1
HUM icon
Humana
HUM
+$4.91M
2
EHC icon
Encompass Health
EHC
+$3.58M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$3.43M
4
AMGN icon
Amgen
AMGN
+$3.35M
5
LLY icon
Eli Lilly
LLY
+$2.53M

Sector Composition

1 Healthcare 48.9%
2 Financials 13.82%
3 Technology 6.61%
4 Consumer Discretionary 5.8%
5 Materials 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NKTR icon
276
CALL
Nektar Therapeutics
NKTR
$2.31B
– –
-1,560
Closed -$8.67K
NUVL icon
277
Nuvalent
NUVL
– –
-1,150
Closed -$87.7K
NVO
278
CALL
Novo Nordisk
NVO
$223B
– –
-231
Closed -$3.94K
OBT icon
279
Orange County Bancorp
OBT
$504M
– –
-9,390
Closed -$243K
OLMA icon
280
Olema Pharmaceuticals
OLMA
$1B
– –
-58,333
Closed -$350K
ORCL icon
281
CALL
Oracle
ORCL
$364B
– –
-100
Closed -$12.4K
ORCL icon
282
Oracle
ORCL
$364B
– –
-2,000
Closed -$437K
PFE icon
283
CALL
Pfizer
PFE
$143B
– –
-462
Closed -$18.2K
PHAT icon
284
Phathom Pharmaceuticals
PHAT
$873M
– –
-9,421
Closed -$90.3K
PINC
285
DELISTED
Premier
PINC
– –
-81,593
Closed -$1.79M
PIPR icon
286
Piper Sandler
PIPR
$5.16B
– –
-8,704
Closed -$605K
PNFP icon
287
Pinnacle Financial Partners Inc
PNFP
$15.3B
– –
-4,207
Closed -$464K
PRTA icon
288
CALL
Prothena Corp
PRTA
$453M
– –
-230
Closed -$4.59K
QURE icon
289
CALL
uniQure
QURE
$2.77B
– –
-239
Closed -$37.9K
RDNT icon
290
RadNet
RDNT
$4.89B
– –
-11,724
Closed -$667K
REPL icon
291
Replimune Group
REPL
$859M
– –
-7,492
Closed -$69.6K
RKT icon
292
CALL
Rocket Companies
RKT
$41.1B
– –
-262
Closed -$57.4K
RKT icon
293
Rocket Companies
RKT
$41.1B
– –
-58,677
Closed -$832K
RVMD icon
294
CALL
Revolution Medicines
RVMD
$39.6B
– –
-461
Closed -$2.05K
RYAAY icon
295
Ryanair
RYAAY
$32.5B
– –
-4,864
Closed -$281K
SCHW
296
Charles Schwab
SCHW
$177B
– –
-7,043
Closed -$643K
SCPH
297
DELISTED
scPharmaceuticals
SCPH
– –
-50,107
Closed -$257K
SEM
298
DELISTED
Select Medical
SEM
– –
-93,563
Closed -$1.42M
SMMT icon
299
Summit Therapeutics
SMMT
$10.7B
– –
-331
Closed -$8.03K
SMMT icon
300
PUT
Summit Therapeutics
SMMT
$10.7B
– –
-873
Closed -$30.5K
9 10 11
12
13

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Persistent Asset Partners held 316 positions worth $145M, up 7.9% from $135M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Persistent Asset Partners withdrew a net $39.5M in Q3 2025, closing 75 positions and reducing 59 holdings. Its most notable exit was Humana, an estimated $4.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 52% a quarter earlier, followed by Financials and Technology.

Against the trend, Persistent Asset Partners opened a new position in Centene worth $8.19M.

  • Persistent Asset Partners's largest Q3 2025 buy was Centene: 229,544 shares worth $8.19M.
  • Persistent Asset Partners added most to Regeneron Pharmaceuticals in Q3 2025, an estimated $3.17M increase.
  • Persistent Asset Partners's biggest Q3 2025 reduction was iShares Bitcoin Trust, cutting an estimated $3.43M.
  • Persistent Asset Partners fully exited Humana in Q3 2025, selling an estimated $4.91M.
  • Persistent Asset Partners's ten largest holdings make up 27% of its $145M portfolio in Q3 2025.
  • Persistent Asset Partners opened 137 new positions and closed 75 in Q3 2025.
  • Persistent Asset Partners's portfolio value rose 7.9% quarter-over-quarter to $145M.

Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.